CATHI Launches First New Generation Right Heart Catheter Simulator

CATHI a German-based endovascular simulator specialist has launched the CATHIS® RHC 2, the first in a new generation of Right Heart Catheter (RHC) simulators.

An RHC, inserted via the jugular or femoral artery, provides an invasive examination of the right heart (atrium and ventricle) which can detect pathological changes via pressure measurement.

This includes central venous pressure; right atrium pressure and right ventricular pressure; pressure in the pulmonary arteries and capillaries; and cardiac output. The differences in blood pressure determine the hemodynamics of the heart, i.e. how effectively it is pumping blood around the body.

In addition, blood samples can be taken at various points to measure oxygen content.

“Characterizing the exact hemodynamics of patients with cardiovascular disease is becoming increasingly important, so improvement in teaching and knowledge transfer in this field is urgently required”, commented Professor Stephan Rosenkranz, Head of the CCRC.

“Hands-on training using state-of-the-art methods offers an excellent opportunity for a sustainable and efficient transfer of knowledge and understanding of hemodynamic relationships. CATHIS® RHC 2, the new innovative simulator developed with CCRC’s expertise, will significantly enrich our training capabilities”.

 

SourceCATHI

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”